APA (7th ed.) Citation

Porta-Etessam, J., González-García, N., Guerrero, Á., & García-Azorín, D. (2021). Failure of monoclonal antibodies against CGRP or its receptor does not imply lack of efficacy of other drugs from the same class. Neurología (Barcelona, English ed. ), 36(8), 638-640. https://doi.org/10.1016/j.nrleng.2020.10.008

Chicago Style (17th ed.) Citation

Porta-Etessam, J., N. González-García, Á.L Guerrero, and D. García-Azorín. "Failure of Monoclonal Antibodies Against CGRP or Its Receptor Does Not Imply Lack of Efficacy of Other Drugs from the Same Class." Neurología (Barcelona, English Ed. ) 36, no. 8 (2021): 638-640. https://doi.org/10.1016/j.nrleng.2020.10.008.

MLA (9th ed.) Citation

Porta-Etessam, J., et al. "Failure of Monoclonal Antibodies Against CGRP or Its Receptor Does Not Imply Lack of Efficacy of Other Drugs from the Same Class." Neurología (Barcelona, English Ed. ), vol. 36, no. 8, 2021, pp. 638-640, https://doi.org/10.1016/j.nrleng.2020.10.008.